CGIM
ETON icon

Cannon Global Investment Management’s Eton Pharmaceutcials ETON Stock Holding History

Cannon Global Investment Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,400
Closed -$148K – 93
2025
Q1 		$148K Buy
+11,400
New +$172K 0.26% 64

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Cannon Global Investment Management's ETON Position: Q2 2025 in Review

Cannon Global Investment Management sold out of Eton Pharmaceutcials (ETON) in Q2 2025, closing a stake of 11,400 shares — an estimated $148K sold.

Cannon Global Investment Management first reported a position in ETON in Q1 2025 and held it in 1 quarter. The position peaked at $148K in Q1 2025. 87 funds tracked by Wall St. Rank hold ETON as of Q2 2025.

  • Cannon Global Investment Management reported no remaining Eton Pharmaceutcials position as of Q2 2025 after selling out during the quarter.
  • Cannon Global Investment Management sold 11,400 Eton Pharmaceutcials shares in Q2 2025, an estimated $148K.
  • Cannon Global Investment Management first reported a position in Eton Pharmaceutcials in Q1 2025 and held it in 1 quarter.
  • Cannon Global Investment Management's Eton Pharmaceutcials position peaked at $148K in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2025.

Based on Cannon Global Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.